Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Conference Correspondent
ASH 2014
ASH 2014 – Castleman's Disease
ASH 2014 - Castleman's Disease
Ibrutinib Monotherapy in Patients with Relapsed/Refractory Follicular Lymphoma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Safety and Efficacy of Ibrutinib plus Rituximab in Relapsed Mantle-Cell Lymphoma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Combination of Ibrutinib and BCL-2 or Spleen Tyrosine Kinase Inhibitors in Ibrutinib-Resistant Diffuse Large B-Cell Lymphoma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Ibrutinib in Patients with Bortezomib-Refractory Mantle-Cell Lymphoma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Ibrutinib in Relapsed/Refractory Mantle-Cell Lymphoma: 2-Year Results of Safety and Durability of Response
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
The Role of Hepcidin in Multicentric Castleman Disease
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Idiopathic Castleman Disease: Clinical Features and Therapeutic Options
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Restoration of Health with Siltuximab in Multicentric Castleman Disease
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Siltuximab Efficacy in Multicentric Castleman’s Disease Is Independent of Baseline Symptom Burden
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Adding Rituximab to CHOP Improves Clinical Outcomes in Mantle-Cell Lymphoma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Page 1 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Addressing Cancer Health Disparities: The No One Left Alone Initiative
Rohan Nathwani
,
Arva Patel
,
Warner Kornberg
,
Asutosh Gor, MD
,
Sashi Naidu, MD
,
Viral Rabara, MD
,
Niyati Nathwani, MD
,
Kashyap Patel, MD
2.
Navigating the Complex Landscape of Oral Cancer Medication
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma